Table 2.
Clinical and demographic characteristics of patients with differentiated thyroid cancer (DTC)
| Variables | DTC |
|---|---|
| Age (years) | |
| Mean ± SD | 43.08 ± 13.6 |
| Interval | 15–71 |
| Gender | |
| Female, n (%) | 69 (87.3) |
| Male, n (%) | 10 (12.7) |
| Diagnosis | |
| Papillary thyroid cancer, n (%) | 76 (96.2) |
| Follicular thyroid cancer, n (%) | 2 (2.5) |
| Mature cystic teratoma, n (%) | 1 (1.2) |
| All group | |
| Follicular variant, n (%) | 46(58.2) |
| Classical type, n (%) | 20 (25.3) |
| Diffuse sclerosan variant, n (%) | 3 (3.7) |
| Solid variant, n (%) | 3 (3.7) |
| Highly cylindrical variant, n (%) | 1 (1.2) |
| Oncositic variant, n (%) | 3 (3.37) |
| Tumor diameter (cm) | |
| Mean ± SD | 2.17 ± 1.69 |
| Interval | 0.4–11.5 |
| Smoking, n (%) | 24(30.3) |
| Radioactive iodine dose(mCi) | |
| Mean ± SD | 141.13 ± 84.2 |
| Interval | 100–500 |